Pharmaceutical CDMO 2.0 Market size was valued at USD 173.9 billion in 2025 and is projected to exceed USD 386 billion by the end of 2035, expanding at over 8.3% CAGR during the forecast period i.e., between 2026-2035. North America industry is projected to account for the largest share, at 41.6% by 2035, owing to a high concentration of large pharmaceutical and biotechnology companies and an advanced regulatory framework.